Lacobris 100mg Tablet contains lacosamide, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing. This mechanism contributes to its efficacy in reducing seizure frequency. Lacobris is typically administered orally, with dosage individualized based on clinical response and tolerability. The recommended starting dose is 50 mg twice daily, which may be gradually increased to a maintenance dose of 100 mg twice daily, not exceeding 400 mg per day. Lacobris is generally well tolerated; common adverse effects include dizziness, headache, nausea, and diplopia. Caution is advised in patients with cardiac conduction abnormalities, as lacosamide may cause PR interval prolongation. It is contraindicated in individuals with known hypersensitivity to lacosamide or any excipients. Regular monitoring of cardiac function and electrolyte levels is recommended during therapy. Lacobris should be used under strict medical supervision, with consideration of potential drug interactions, particularly with other antiepileptic drugs and medications affecting cardiac conduction. This medication is intended to improve seizure control and enhance quality of life in patients with epilepsy.